ADMA BIOLOGICS, INC. (ADMA) Operating income 2016–2025
ADMA BIOLOGICS, INC. (ADMA) annual operating income history from SEC filings — each fiscal year as reported.
$191.4MFY2025 · since FY2016: -$17.3M → $191.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $191.4M | +37.7% |
| FY2024 | $139.0M | +542.5% |
| FY2023 | $21.6M | +155.0% |
| FY2022 | -$39.4M | +32.6% |
| FY2021 | -$58.4M | +10.1% |
| FY2020 | -$64.9M | -56.7% |
| FY2019 | -$41.4M | +31.3% |
| FY2018 | -$60.3M | -53.4% |
| FY2017 | -$39.3M | -126.8% |
| FY2016 | -$17.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice